When was ADVOCATE SOUTHWEST AMBULATORY SURGERY CENTER, L.L.C.'s most recent SEC filing?

ADVOCATE SOUTHWEST AMBULATORY SURGERY CENTER, L.L.C.'s most recent Form D filing was on 2026-11-02.

What type of securities does ADVOCATE SOUTHWEST AMBULATORY SURGERY CENTER, L.L.C. offer?

ADVOCATE SOUTHWEST AMBULATORY SURGERY CENTER, L.L.C.'s SEC Form D filings indicate equity offerings.

ADVOCATE SOUTHWEST AMBULATORY SURGERY CENTER, L.L.C.

CIK: 0001129397·Other Health Care·TINLEY PARK, IL·Limited Liability Company

Reported Sold

$277,100

Total Filings

Identified Offerings

Last Filed

Nov 2, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Nov 2, 2026Form D — New notice

Reported sold: $0 · Target: $188,724

Rule 506(b)·0 investors

Dec 18, 2025Form D — New notice

Reported sold: $0 · Target: $110,386

Rule 506(b)·0 investors

Nov 26, 2024Form D — New notice

Reported sold: $0 · Target: $95,718

Rule 506(b)·0 investors

Aug 9, 2023Form D/A — Amendment

Reported sold: $60,000 · Target: $82,500

Rule 506(b)·3 investors

Changed: Reported amount sold, Offering target, Reported investors

Jul 5, 2023Form D/A — Amendment

Reported sold: $30,000 · Target: $60,000

Rule 506(b)·1 investor

Changed: Reported amount sold, Offering target, Reported investors

Jun 9, 2023Form D — New notice

Reported sold: $0 · Target: $30,000

Rule 506(b)·0 investors

Nov 8, 2022Form D/A — Amendment

Reported sold: $211,600 · Target: $211,600

Section 4(a)(2)·1 investor

Changed: Reported amount sold, Offering target, Reported investors

Jun 22, 2022Form D — New notice

Reported sold: $0 · Target: $193,200

Section 4(a)(2)·0 investors

Jan 19, 2022Form D — New notice

Reported sold: $5,500 · Target: $49,500

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 6 identified offerings

$277,100

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Silvio Marra

Executive Officer, Director

Appears on 9 filings

Amy Sinder

Director

Appears on 6 filings

Rolla Sweis

Related Person

Appears on 6 filings

Bradley Silverman

Executive Officer, Director

Appears on 5 filings

Nirav Thakkar

Related Person

Appears on 4 filings

Samuel Multack

Director

Appears on 3 filings

Tara Jeschke

Related Person

Appears on 3 filings

Deb Gardiner

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 2, 2026	New	$188,724	$0	0
Dec 18, 2025	New	$110,386	$0	0
Nov 26, 2024	New	$95,718	$0	0
Aug 9, 2023	Amendment	$82,500	$60,000	3
Jul 5, 2023	Amendment	$60,000	$30,000	1
Jun 9, 2023	New	$30,000	$0	0
Nov 8, 2022	Amendment	$211,600	$211,600	1
Jun 22, 2022	New	$193,200	$0	0
Jan 19, 2022	New	$49,500	$5,500	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Valvara, Inc

Other Health Care

Offering target: $250,000

Filed May 27, 2026